You are here: Industry Insights > stock

News List

The Biggest Winners and Losers of JPM 2018 biospace
January 18, 2018
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference. CNBC’s Jim Cramer made his picks related to stock performance.
Array BioPharma (ARRY) Price Target Increased to $13.00 by Analysts at Jefferies Group americanbankingnews
December 26, 2017
Array BioPharma (NASDAQ:ARRY) had its price objective raised by equities research analysts at Jefferies Group to $13.00 in a note issued to investors on Friday
MyDx Cancels Reverse Stock Split prnasia
December 21, 2017
MYDX, a science and technology company and creator of MyDx®, the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailmen
Argenx Announces Closing of U.S. Public Offering for Gross Proceeds of Approximately $26M biospace
December 20, 2017
argenx's ADSs are currently listed on the Nasdaq Global Select Market under the symbol "ARGX," and argenx's ordinary shares are currently listed on Euronext Brussels.
Allergan embarks on $2 billion share repurchase pharmatimes
September 27, 2017
Allergan is to embark on a new $2 billion share repurchase programme – soon after it completed a separate buyback of $15 billion in its own shares.

Previous page 1 2 Next page